Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
NGNE Neurogene
- 18.420
- -0.350-1.86%
Close Feb 14 16:00 ET
- 18.420
- 0.0000.00%
Post 20:01 ET
273.62MMarket Cap-6.50P/E (TTM)
19.970High18.086Low102.86KVolume18.750Open18.770Pre Close1.92MTurnover1.95%Turnover RatioLossP/E (Static)14.85MShares74.49052wk High1.99P/B97.35MFloat Cap14.42052wk Low--Dividend TTM5.29MShs Float1115.000Historical High--Div YieldTTM10.04%Amplitude7.500Historical Low18.643Avg Price1Lot Size
About Neurogene Company
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
Company Profile
SymbolNGNE
Company NameNeurogene
Listing DateMar 7, 2014
Founded2007
CEOMr. Richard K. Matros
MarketNASDAQ
Employees91
Fiscal Year Ends12-31
Address535 West 24th Street,5th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10011
Phone1-877-237-5020
Websitehttp://www.neurogene.com
Company Executives
- Name
- Position
- Salary
- Dr. Rachel McMinn, PhD
- Executive Chairman of the Board and Chief Executive Officer
- 1.08M
- Christine Mikail Cvijic, J.D.
- President and Chief Financial Officer
- 1.13M
- Dr. Julie Jordan, M.D.
- Chief Medical Officer
- --
- Dr. Stuart Cobb, PhD
- Chief Scientific Officer
- 784.32K
- Donna Cochener
- Senior Vice President and General Counsel
- --
- Rohan Palekar
- Independent Director
- 71.62K
- Dr. Sarah B. Noonberg, M.D.,PhD
- Independent Director
- 62.12K
- Robert Keith Woods
- Independent Director
- --
- Dr. Robert A. Baffi,PhD
- Independent Director
- 64.08K
- Dr. Cory Freedland, PhD
- Independent Director
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.